Anurag Agrawal
Ashoka University, CSIR Institute of Genomics & Integrative Biology, University of Delhi, Baylor College of Medicine, All India Institute of Medical Sciences
About
Anurag Agrawal is Dean Biosciences and Health Research at Trivedi School of Biosciences, Ashoka University, and a former director of the CSIR Institute of Genomics & Integrative Biology (IGIB). He graduated in medicine from the All India Institute of Medical Sciences in 1994, followed by specialization in Internal Medicine, Pulmonary Disease, and Critical Care from Baylor College of Medicine, Houston, (2003) and a PhD in physiology. After serving as a faculty member at Baylor, he joined IGIB in 2007. His research in respiratory health has covered a full spectrum from molecular pathobiology to informatics and epidemiology, leading to his being awarded the Shanti Swaroop Bhatnagar award for Medical Sciences and the Wellcome Trust India Alliance senior fellowship in 2014, followed by the National Bioscience Award in 2015. His additional interests are in the use of information technology in health, specifically the interface between digital medicine, machine learning, and public health.
Employment
-
Ashoka University Dean, Biosciences and health Research2022 - Present
-
CSIR Institute of Genomics & Integrative Biology Principal Scientist2007 - 2022
-
Baylor College of Medicine GME, Assistant Professor (2003 onwards)1996 - 2007
Education
-
University of Delhi PhD2003 - 2007
-
Baylor College of Medicine Diplomate American Board (Medicine, Pulmonary Disease, Critical Care)1996 - 2003
-
All India Institute of Medical Sciences MBBS1989 - 1995
Projects & Funding
Projects & funding information is unavailable.
Publications (284)
- The Reality of AI and Biorisk Save
- The role of mitochondrial DNA copy number in asthma: Agent or bystander? Save
- MDA-GAN: Multiscale and Dual Attention Generative Adversarial Network for Bone Suppression in Chest X-Rays Save
- An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution Save
- Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Save
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Save
- Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Save
- Making digital transformations work for health: introducing a new consortium to take forward recommendations from the Lancet and Financial Times Commission Save
- Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study Save
- Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis Save